Gynoclear™, a formulation of six herbs, could potentially reduce the severity and duration of pain and other symptoms associated with endometriosis.
The methodology consisted of a randomized, double-blind, placebo-controlled trial with a minimum of 90 participants across Australia who have confirmed endometriosis and moderate or greater pelvic pain. These participants were equally divided to receive either Gynoclear™ or a placebo. Gynoclear's active ingredients consist of six herbs, namely Safflower, Chinese cinnamon, Hoelen, Tree peony, Peony, and Red sage. The participants were required to document their pain experiences for a total of five months, which included a month of screening, two months of treatment, and a month post-treatment. The main variable being studied was the change in endometriosis-related pain.
The results of the study aimed to establish the efficacy of Gynoclear™ in reducing endometriosis-related pain and other symptoms. Secondary outcomes encompassed change in health-related quality of life, alterations in the use of rescue analgesics, and changes in sexual discomfort and fatigue. The practicality and usefulness of Gynoclear™ intended to serve both healthcare professionals and individuals suffering from endometriosis.
